![](/img/cover-not-exists.png)
CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy
Ramachandran, Raja, Yadav, Ashok K., Kumar, Vinod, Gupta, Krishan L., Kohli, Harbir S.Language:
english
Journal:
Kidney International Reports
DOI:
10.1016/j.ekir.2016.08.019
Date:
September, 2016
File:
PDF, 138 KB
english, 2016